Aikido pharma issues update on antiviral platform with the university of maryland

New york, july 16, 2021 /prnewswire/ -- aikido pharma inc. (nasdaq: aiki) ("aikido" or the "company") today provided an update to the progress of its antiviral platform with the university of maryland school of medicine.  the company stated: the goal for the project is the identification and optimization of anti-viral compounds that inhibit viral replication by targeting a protein complex that degrades rna at the cellular level.
DOMH Ratings Summary
DOMH Quant Ranking